These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9003073)
1. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors. Gaudriault G; Zsürger N; Vincent JP J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073 [TBL] [Abstract][Full Text] [Related]
2. Receptor-induced internalization of selective peptidic mu and delta opioid ligands. Gaudriault G; Nouel D; Dal Farra C; Beaudet A; Vincent JP J Biol Chem; 1997 Jan; 272(5):2880-8. PubMed ID: 9006932 [TBL] [Abstract][Full Text] [Related]
3. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding. Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6. Biondi L; Giannini E; Filira F; Gobbo M; Marastoni M; Negri L; Scolaro B; Tomatisc R; Rocchi R J Pept Sci; 2003 Oct; 9(10):638-48. PubMed ID: 14620129 [TBL] [Abstract][Full Text] [Related]
5. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor. Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor. Attila M; Salvadori S; Balboni G; Bryant SD; Lazarus LH Int J Pept Protein Res; 1993 Dec; 42(6):550-9. PubMed ID: 7905867 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence. Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596 [TBL] [Abstract][Full Text] [Related]
8. Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion. Lazarus LH; Guglietta A; Wilson WE; Irons BJ; de Castiglione R J Biol Chem; 1989 Jan; 264(1):354-62. PubMed ID: 2562839 [TBL] [Abstract][Full Text] [Related]
9. Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography. Mokhtari M; Tafani JA; Zajac JM Neuropeptides; 1993 Sep; 25(3):183-91. PubMed ID: 8247256 [TBL] [Abstract][Full Text] [Related]
10. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy. Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and binding properties of deltorphin I analogues containing (R) and (S)-alpha-hydroxymethylnaphtylalanine. Olma A; Gniadzik A; Lipkowski AW; Lachwa M Acta Biochim Pol; 2001; 48(4):1165-8. PubMed ID: 11995986 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of [D-Ala2,4'-125I-Phe3,Glu4]deltorphin and characterization of its delta opioid receptor binding properties. Fang L; Knapp RJ; Matsunaga T; Weber SJ; Davis T; Hruby VJ; Yamamura HI Life Sci; 1992; 51(20):PL189-93. PubMed ID: 1331636 [TBL] [Abstract][Full Text] [Related]
13. The impact of β-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and conformation of dermorphin analogues. Maciejczyk M; Lasota A; Frączak O; Kosson P; Misicka A; Nowakowski M; Ejchart A; Olma A J Pept Sci; 2016 Aug; 22(8):545-51. PubMed ID: 27443980 [TBL] [Abstract][Full Text] [Related]
14. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor. Charpentier S; Sagan S; Delfour A; Nicolas P Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides. Breveglieri A; Guerrini R; Salvadori S; Bianchi C; Bryant SD; Attila M; Lazarus LH J Med Chem; 1996 Feb; 39(3):773-80. PubMed ID: 8576920 [TBL] [Abstract][Full Text] [Related]
17. Binding to delta and mu opioid receptors by deltorphin I/II analogues modified at the Phe3 and Asp4/Glu4 side chains: a report of 32 new analogues and a QSAR study. Schullery SE; Mohammedshah T; Makhlouf H; Marks EL; Wilenkin BS; Escobar S; Mousigian C; Heyl DL Bioorg Med Chem; 1997 Dec; 5(12):2221-34. PubMed ID: 9459020 [TBL] [Abstract][Full Text] [Related]
18. [125I][D-Ala2]deltorphin-I: a high affinity, delta-selective opioid receptor ligand. Dupin S; Tafani JA; Mazarguil H; Zajac JM Peptides; 1991; 12(4):825-30. PubMed ID: 1664947 [TBL] [Abstract][Full Text] [Related]
19. Quantitative autoradiographic mapping of delta-opioid receptors in the rat central nervous system using [125I][D.Ala2]deltorphin-I. Gouardères C; Tellez S; Tafani JA; Zajac JM Synapse; 1993 Mar; 13(3):231-40. PubMed ID: 8388577 [TBL] [Abstract][Full Text] [Related]
20. Opioid ligands with extraordinarily high mu-selectivity: dermorphin tetrapeptides containing thymine-modified alanine residues. Kharkevich DA; Sumbatyan NV; Topin AN; Chichenkov ON; Zaitsev SV; Korshunova GA FEBS Lett; 1994 Sep; 351(3):308-10. PubMed ID: 7915993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]